European equities traded in the US as American depositary receipts were little changed late Friday morning, edging 0.03% higher to 1,593.26 on the S&P Europe Select ADR Index, which is up about 0.5% for the week.

From continental Europe, the gainers were led by pharmaceutical company Sanofi (SNY) and biotech firm Evaxion (EVAX), which rose 3.8% and 4.8% respectively. They were followed by biopharmaceutical companies DBV Technologies (DBVT) and Genfit (GNFT), which were up 4.9% and 1.2% respectively.

The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and software firm SAP (SAP), which fell 7.9% and 2% respectively. They were followed by petroleum refiner Equinor (EQNR) and medical device manufacturer EDAP TMS (EDAP), which were down 2.8% and 2% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Biodexa Pharmaceuticals (BDRX) and Akari Therapeutics (AKTX), which advanced 5% and 2.8% respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and hospitality company InterContinental Hotels Group (IHG), which increased 2.7% and 1.9% respectively.

The decliners from the UK and Ireland were led by pharmaceutical company GSK (GSK) and biopharmaceutical company Adaptimmune Therapeutics (ADAP), which dropped 5.1% and 9.7% respectively.